Agent Name
Phenylhydrazine
Major Category
Nitrogen Compounds
Synonyms
Fenilidrazina [Italian]; Fenylhydrazine [Dutch]; Hydrazine, phenyl-; Hydrazine-benzene; Hydrazinobenzene; Hydrazobenzene; Monophenylhydrazine; Phenylhydrazin [German]; Phenylhydrazine; [ChemIDplus] UN2572
Description
Colorless to pale-yellow liquid or solid (below 67 degrees F) with a faint, aromatic odor; [NIOSH]
Sources/Uses
Used in the synthesis of dyes and pharmaceuticals; [ACGIH]
Comments
Hemolytic anemia has been observed in workers after inhalation and dermal exposures. [ACGIH] Phenylhydrazine is a potent skin sensitizer and can cause hemolytic anemia by all routes of exposure. Toxic effects were observed in patients treated for polycythemia with doses of 0.2 G/day for 3 or 4 doses, then 0.1 G/day. Adverse effects included hemolytic anemia, liver injury, and methemoglobinemia. [HSDB] Can cause hemolytic anemia and skin sensitization; [ICSC] Causes first-degree burns on short exposure and second-degree burns on prolonged exposure; [CHRIS]
Skin Designation (ACGIH)
Yes
Excerpts from Documentation for IDLHs
No data on acute or chronic inhalation toxicity are available on which to base the IDLH. Systemic effects described by Patty [1963] were caused by chronic exposures from oral dosing. NIOSH [1976] cited a rat oral LD50 of 188 mg/kg [Ekshtat 1965] which provides a calculated estimate of 1,300 mg/m3 (295 ppm) for the IDLH.
Vapor Pressure
0.026 mm Hg
Lethal Concentration
LC50 (rat) = 2,610 mg/m3
Explanatory Notes
Flash point = 88 deg C; VP from HSDB;
NFPA
high ambient temp required
Methemoglobinemia
MetHgb is secondary toxic effect
Hepatotoxin
Hepatoxic (a) from occupational exposure (secondary effect) or (b) in animal studies or in humans after ingestion
ACGIH Carcinogen
Confirmed Animal
Diseases
Occupational diseases associated with exposure to this agent: